š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
This randomized phase III trial is comparing the effectiveness of three adj...
Status
Completed
Location
Eastern Cooperative Oncology Group
Start Date
2003-10-15
Trial ID
NCT00068692
Treatments Being Tested
To evaluate the safety of the combination of trimetrexate glucuronate (TMTX...
Status
Completed
Location
Los Angeles County / Health Research Assoc / Drew Med Ctr
Start Date
TBD
Trial ID
NCT00002120
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as oxaliplatin, irinotecan, leu...
Status
Completed
Location
California Cancer Care, Incorporated - Greenbrae
Start Date
2005-09-08
Trial ID
NCT00098787
Treatments Being Tested
The purpose of this study is to explore the physical exam characteristics o...
Status
Unknown
Location
The Bone and Joint Center
Start Date
2022-05-07
Trial ID
NCT06142370
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
Arizona Cancer Center
Start Date
1999-03
Trial ID
NCT00003783
The objective of this protocol is to improve survival for adults with acute...
Status
Terminated
Location
UCSD, Division of Blood and Marrow Transplantation, Moores Cancer Center
Start Date
2014-01
Trial ID
NCT02043587
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
Via Christi Regional Medical Center-Saint Francis Campus
Start Date
1994-12
Trial ID
NCT00002618
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
CCOP - Colorado Cancer Research Program, Inc.
Start Date
1999-06-01
Trial ID
NCT00003298
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
Start Date
2000-06
Trial ID
NCT00004228
This is a Phase 3, multicenter, randomized and double-blind study assessing...
Status
Unknown
Location
Multiple Locations
Start Date
2022-08-01
Trial ID
NCT05378867
Treatments Being Tested